Clinical Trials Directory

Trials / Completed

CompletedNCT04069546

The Efficacy of Remote Ischemic Conditioning on Stroke-induced Immunodeficiency

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

to detect the effects of RIC on stroke-induced immunodeficiency and inflammation response in acute ischemic stroke patients

Detailed description

Remote ischemic conditioning, consisting of several brief cycles of intermittent ischemia-reperfusion of the arm or leg, may potentially confer systemic protection against prolonged ischemia in a distant organ. Numerous reports have confirmed its strongest endogenous neuroprotection against brain injury after stroke, of which the immune mechanisms are majorly involved in RIC. At the same time, the inflammation response plays a great role in stroke development, which may expand the infarct area. Stroke-induced immunodeficiency can potentiate stroke-associated pneumonia, which is an important cause of death after strokes. In this study, the investigators will assess the effect of RIC on stroke-induced immunodeficiency and inflammation response in AIS patients.

Conditions

Interventions

TypeNameDescription
DEVICEremote ischemic conditioningRIC is a physical strategy performed by an electric device with cuffs placed on the unilateral arm and inflated to 180 mmHg for 5-min followed by deflation for 5-min, the procedures are performed repeatedly for 5 times.

Timeline

Start date
2019-09-07
Primary completion
2020-02-01
Completion
2020-02-01
First posted
2019-08-28
Last updated
2020-12-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04069546. Inclusion in this directory is not an endorsement.